Passage Bio, Inc. (PASG) Misses Q3 EPS by 8c

Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Trex (TREX) Reiterated at Hold by Benchmark as Partnership Agreement Announced
• The Chefs' Warehouse, Inc (CHEF) PT Raised to $106 at Benchmark on Growth Assumption
• Bank of America (BAC) Tops Q2 EPS by 9c, Beats on Revenue